{"id":176226,"date":"2026-08-12T13:18:00","date_gmt":"2026-08-12T13:18:00","guid":{"rendered":"https:\/\/pabau.com\/?p=176226"},"modified":"2026-08-13T06:57:09","modified_gmt":"2026-08-13T06:57:09","slug":"hcpcs-code-j0153","status":"publish","type":"post","link":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/","title":{"rendered":"HCPCS code J0153: Adenosine injection 1 mg billing guide"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"HCPCS code J0153: Adenosine injection 1 mg billing guide\",\"description\":\"Complete reference for HCPCS code J0153 (Injection, adenosine, 1 mg). Covers fee schedule, NDC crosswalk, billing guidelines, the deleted predecessor codes J0150 and J0151, and common compliance errors.\",\"url\":\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0153\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-08-10\",\"dateModified\":\"2026-08-13\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>HCPCS code J0153 covers injection, adenosine, 1 mg. It is billed per 1 mg unit, most often for pharmacological cardiac stress testing.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>J0153 took effect on January 1, 2015. It absorbed two codes deleted that day, J0150 (therapeutic use, 6 mg) and J0151 (diagnostic use, 1 mg).<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>J0153 must not be used for adenosine phosphate compounds. The exclusion sits inside the official descriptor, so misuse is a compliance violation.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Both branded adenosine products, Adenocard and Adenoscan, are discontinued. Almost every J0153 claim today carries a generic NDC.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>NDC reporting is required on every Medicare Part B claim for J0153. Omitting the NDC is a top denial trigger.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Practice management software like Pabau attaches the NDC and applies the right fee schedule before a J0153 claim leaves the building.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">HCPCS code J0153 is the current active code for adenosine injection, billed per 1 mg. The Centers for Medicare and Medicaid Services (<a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/healthcare-common-procedure-system\" target=\"_blank\" rel=\"nofollow noopener\">CMS<\/a>) maintains the official descriptor. It reads &#8220;Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds).&#8221; That parenthetical exclusion carries the same weight as the rest of the descriptor. Billing J0153 for an adenosine phosphate product is a compliance violation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">J0153 took effect on January 1, 2015. It replaced two codes deleted the same day. J0150 covered adenosine for therapeutic use in 6 mg increments, and J0151 covered adenosine for diagnostic use in 1 mg increments. HCPCS 2015 folded both into one per-milligram code that applies whether the drug is given to diagnose or to treat.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">J0153 covers every adenosine injection product, branded or generic. The two branded versions, Adenocard and Adenoscan, both came from Astellas Pharma US and were manufactured by Hospira. FDA lists both as discontinued, so the supply reaching US practices today is generic.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The coder&#8217;s job is to confirm the administered drug is adenosine, not an adenosine phosphate compound. Units are then calculated from the dose given.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J0153<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Official descriptor<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS category<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Level II, J-code (drugs administered other than oral method)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Unit of service<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 1 mg<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Effective date<\/td>\n<td style=\"padding:12px 16px;color:#374151\">January 1, 2015 (active)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Codes replaced<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J0150 and J0151, both deleted January 1, 2015<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Termination date<\/td>\n<td style=\"padding:12px 16px;color:#374151\">None (currently active)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Type of service<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Medicare Part B separately payable drug<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Brand equivalent<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Adenocard and Adenoscan, both from Astellas Pharma US and now discontinued. Generic adenosine products map to this code.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<h2 id=\"h-clinical-use-when-is-adenosine-injection-indicated\" class=\"wp-block-heading\">Clinical use: When is adenosine injection indicated?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Adenosine&#8217;s primary clinical application is pharmacological cardiac stress testing. When a patient cannot exercise adequately, physicians give adenosine as a vasodilator to mimic the effects of exertion. The drug dilates coronary arteries, revealing perfusion deficits that myocardial perfusion imaging (MPI) can capture. A <a href=\"https:\/\/pabau.com\/blog\/thallium-stress-test\/\">thallium stress test<\/a> is one common form of that imaging.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Adenosine also treats supraventricular tachycardia (SVT). That is a distinct clinical context with different billing considerations, so confirm the documented indication before selecting J0153. Outpatient infusion settings running <a href=\"https:\/\/pabau.com\/industry\/iv-therapy-emr-software\/\">IV therapy EMR software<\/a> see both scenarios, and the drug record is what separates them.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Myocardial perfusion imaging (MPI):<\/strong> The most common billing context for J0153. Adenosine is infused continuously during nuclear stress testing.<\/li>\n\n\n\n<li><strong>Coronary flow reserve testing:<\/strong> Used alongside invasive coronary procedures in catheterization labs, where measures such as <a href=\"https:\/\/pabau.com\/templates\/fick-cardiac-output\/\">Fick cardiac output<\/a> are recorded too.<\/li>\n\n\n\n<li><strong>SVT treatment:<\/strong> Rapid IV bolus in emergency or outpatient settings. Confirm the product is adenosine, not an adenosine phosphate compound, before coding J0153.<\/li>\n\n\n\n<li><strong>Pharmacological stress echocardiography:<\/strong> Less common. Verify payer policy first, since some MAC LCDs restrict coverage to specific imaging modalities.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-j0153-billing-guidelines-and-coding-rules\" class=\"wp-block-heading\">J0153 billing guidelines and coding rules<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Three rules govern every J0153 claim: correct unit count, NDC attachment, and proper place of service. Missing any one of them is the fastest route to a denial. Drug lines behave differently from procedure lines in <a href=\"https:\/\/pabau.com\/blog\/what-is-medical-billing\/\">medical billing<\/a>, because the product itself has to be identified on the claim.<\/p>\n\n\n\n<h3 id=\"h-units-of-service\" class=\"wp-block-heading\">Units of service<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">J0153 is billed per 1 mg. If a patient receives 24 mg of adenosine during a stress test infusion, the claim should reflect 24 units. Coders must confirm the administered dose in the clinical note or infusion record, not default to a standard dose. Dose varies by patient weight and protocol.<\/p>\n\n\n\n<h3 id=\"h-discarded-drug-and-the-jw-and-jz-modifiers\" class=\"wp-block-heading\">Discarded drug and the JW and JZ modifiers<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">CMS requires a discarded-drug modifier on separately payable Part B drugs supplied in single-dose containers. Use JW on a separate line to report the amount discarded, and JZ on the J0153 line to attest that nothing was discarded. Check the packaging of the adenosine product you stock first, because multi-dose vials fall outside the requirement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The modifier has to agree with the dose in the record. Say the note documents 24 mg drawn from a vial holding more. The discarded remainder belongs on a JW line, not folded into the billed units.<\/p>\n\n\n\n<h3 id=\"h-the-adenosine-phosphate-compound-exclusion\" class=\"wp-block-heading\">The adenosine phosphate compound exclusion<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The exclusion in the J0153 descriptor is one of the most-cited compliance traps in J-code billing. Adenosine phosphate compounds are chemically distinct from adenosine and carry their own HCPCS codes. They are sometimes marketed for circulatory conditions or sold as nutritional supplements. Billing J0153 for one of them is incorrect regardless of payer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Document the exact drug name and NDC from the administered vial before coding. The <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/ndc\/\" target=\"_blank\" rel=\"nofollow noopener\">FDA NDC directory<\/a> will confirm what the product actually contains.<\/p>\n\n\n\n<h3 id=\"h-place-of-service\" class=\"wp-block-heading\">Place of service<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">J0153 is billed in hospital outpatient departments, physician offices, ambulatory surgical centers (ASCs), and independent diagnostic testing facilities (IDTFs). The reimbursement rate differs by setting under the Medicare Outpatient Prospective Payment System (OPPS) versus the Physician Fee Schedule. Confirm the place of service code before release, since the same dose pays differently in an office and in a hospital.<\/p>\n\n\n\n<h2 id=\"h-j0153-fee-schedule-and-medicare-reimbursement-rates\" class=\"wp-block-heading\">J0153 fee schedule and Medicare reimbursement rates<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medicare pays for J0153 under the Average Sales Price (ASP) + 6% methodology. ASP-based rates are updated by CMS every quarter, so any specific dollar figure in a reference article is likely outdated within 90 days. Always pull the current rate before submitting a claim or verifying reimbursement. The <a href=\"https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search\/overview\" target=\"_blank\" rel=\"nofollow noopener\">CMS Physician Fee Schedule<\/a> lookup and the quarterly ASP files are the two sources to use.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Reimbursement also differs by setting. The same J0153 claim submitted under the Physician Fee Schedule pays differently from a claim processed under OPPS at a hospital outpatient department. Practices should use <a href=\"https:\/\/pabau.com\/blog\/practice-management-software\/\">practice management software<\/a> that applies the correct fee schedule by place of service automatically. Manual rate lookups go stale within a quarter.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Setting<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Payment basis<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Rate source<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Physician office \/ non-facility<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ASP + 6% (non-facility rate)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">CMS quarterly ASP pricing file<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Hospital outpatient \/ facility<\/td>\n<td style=\"padding:12px 16px;color:#374151\">OPPS APC payment<\/td>\n<td style=\"padding:12px 16px;color:#374151\">CMS OPPS addendum B<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Ambulatory surgical center (ASC)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ASC drug payment (separately payable if not packaged)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">CMS ASC payment addendum<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Independent diagnostic testing facility (IDTF)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Physician Fee Schedule (non-facility rate)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">CMS quarterly ASP pricing file<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<h2 id=\"h-j0153-ndc-crosswalk-linking-the-drug-to-the-claim\" class=\"wp-block-heading\">J0153 NDC crosswalk: Linking the drug to the claim<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CMS requires that Medicare Part B claims for separately payable drugs include the National Drug Code (NDC) of the product administered. For J0153, the NDC reported must correspond to an adenosine injection product, not an adenosine phosphate formulation. That rule covers every separately payable Part B drug, including infusion products such as <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j2323\/\">J2323<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The NDC-to-HCPCS crosswalk file published quarterly by CMS maps approved NDCs to J0153. Coders working from a stale crosswalk submit mismatched NDCs, which triggers automated denials. <a href=\"https:\/\/pabau.com\/blog\/ehr-integration\/\">EHR integration<\/a> that pulls the NDC at the point of dispensing removes most of that manual lookup.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The table below reflects representative manufacturers and product types. Verify against the current CMS crosswalk before submission, since generic manufacturers and NDC assignments change often. Practices that log every vial into <a href=\"https:\/\/pabau.com\/blog\/benefits-of-automating-clinic-inventory-management\/\">inventory management<\/a> keep the lot and expiration alongside the NDC, which is what an auditor asks for.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Product type<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Example manufacturer<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Adenocard and Adenoscan (branded)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Astellas Pharma US, manufactured by Hospira<\/td>\n<td style=\"padding:12px 16px;color:#374151\">FDA lists both as discontinued. Legacy NDCs may still sit in old charge master lines<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Generic adenosine injection<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Mylan Institutional, Gland Pharma, Eugia US, Meitheal and others<\/td>\n<td style=\"padding:12px 16px;color:#374151\">NDC varies by manufacturer. Verify against the current CMS crosswalk file each quarter<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Adenosine phosphate compounds<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Not applicable<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Never use J0153 for these products. Separate codes apply<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">On a CMS-1500 or electronic claim, report the NDC in the shaded area of box 24A. On the 837P it belongs in loop 2410. Add the matching unit qualifier, which is UN for units, GR for grams, or F2 for international units. For adenosine, UN is the standard qualifier.<\/p>\n\n\n\n<h2 id=\"h-related-adenosine-hcpcs-codes\" class=\"wp-block-heading\">Related adenosine HCPCS codes: J0150, J0151, and J0152<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Coders researching adenosine billing still run into J0150, J0151, and J0152. All three are deleted, and none of them can be submitted today. The table below shows what each one covered and when it was retired. That distinction matters, because only two of them are genuine predecessors of J0153.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">J0150 and J0151 are the codes J0153 actually absorbed. Both were deleted on January 1, 2015, the day J0153 took effect. J0152 is the one that trips people up. It was deleted on January 1, 2014, a full year before J0153 existed, so treating it as a J0153 predecessor misreads the record.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Descriptor<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Status<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J0150<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, adenosine for therapeutic use, 6 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Deleted January 1, 2015<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Consolidated into J0153; report actual milligrams administered instead of 6 mg increments<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J0151<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, adenosine for diagnostic use, 1 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Deleted January 1, 2015<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Consolidated into J0153; the diagnostic versus therapeutic split no longer applies<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J0152<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, adenosine for diagnostic use, 30 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Deleted January 1, 2014<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Retired a year before J0153 existed, so it is not a predecessor of J0153<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J0153<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)<\/td>\n<td style=\"padding:12px 16px;color:#374151\"><strong>Active since January 1, 2015<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#374151\">Current code; billed per 1 mg whatever the clinical intent<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The 2015 consolidation is what still catches older systems out. Charge masters built before that date often carry two adenosine lines, one for diagnostic use and one for therapeutic use. That is how the code set was structured at the time. That split is gone. One code now carries every adenosine injection claim, and the unit count does all the work.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Audit your charge description master once a year and confirm J0150 and J0151 no longer appear on any active line. J0152 should be gone as well, since it was deleted back in 2014. Billing a deleted code is a common cause of preventable rejections. It happens at facilities that updated their clinical protocols but never revisited the CDM.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-cpt-codes-commonly-billed-alongside-j0153-for-stress-testing\" class=\"wp-block-heading\">CPT codes commonly billed alongside J0153 for stress testing<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J0153 is almost never submitted in isolation. The drug is the billable component, but the imaging or monitoring procedure carries its own CPT code. Payers link the drug&#8217;s coverage to the procedure&#8217;s indication, so a supervision or component error on <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-93015\/\">93015<\/a> can take the drug line down with it.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">CPT code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Context<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">78451<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Myocardial perfusion imaging, tomographic (SPECT), single study<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Most common pairing with J0153 in nuclear stress testing<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">78452<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Myocardial perfusion imaging, tomographic (SPECT), multiple studies<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Rest and stress studies on same day<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">78453<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Myocardial perfusion imaging, planar, single study<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Less common; verify payer accepts planar imaging for adenosine protocol<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">93015<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Cardiovascular stress test, complete (physician supervision, with report)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Billed when physician directly supervises and interprets the stress component<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">93017<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Cardiovascular stress test, tracing only<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Technical component only; pair with J0153 in facility-only billing<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">93018<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Cardiovascular stress test, physician interpretation and report<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Professional component only; often split-billed with 93017<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Outside stress testing, the administration code changes. When adenosine is pushed to convert SVT, the service is reported with <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-96374\/\">96374<\/a> rather than a stress test CPT.<\/p>\n\n\n\n<h2 id=\"h-icd-10-diagnosis-codes-that-support-medical-necessity\" class=\"wp-block-heading\">ICD-10 diagnosis codes that support medical necessity<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Payers tie adenosine coverage to the reason the stress test was ordered. The diagnosis on the claim has to explain why the patient needed pharmacological stress instead of exercise. Arrhythmia diagnoses such as <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-i499\/\">I49.9<\/a> show up instead when adenosine is given to treat rather than to test.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The codes below appear most often on J0153 claims. Every MAC publishes its own covered list, so check the LCD for your jurisdiction before relying on any of them.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-10 code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Typical context<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">I20.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Unstable angina<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Chest pain workup where exercise stress testing is unsafe<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">I20.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Angina pectoris, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Documented angina without a more specific classification<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">I25.10<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Atherosclerotic heart disease of native coronary artery without angina pectoris<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Known coronary disease under periodic surveillance<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">R07.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Chest pain, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Undifferentiated chest pain referred for perfusion imaging<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">R94.30<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Abnormal result of cardiovascular function study, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Follow-up on an abnormal or inconclusive prior study<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Z95.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Presence of aortocoronary bypass graft<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Graft surveillance after bypass surgery<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">I47.10<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Supraventricular tachycardia, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Adenosine given to treat SVT rather than to stress the heart; confirm payer coverage<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The diagnosis alone rarely carries a claim through a prepayment review. Pair it with a note explaining why exercise stress was ruled out. Beta blocker therapy, orthopedic limitation, deconditioning, and left bundle branch block are the reasons MACs see most often on adenosine claims.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Diabetes and obesity sit behind many of those referrals, so practices running a <a href=\"https:\/\/pabau.com\/industry\/metabolic-health-emr\/\">metabolic health EMR<\/a> handle these claims regularly. A <a href=\"https:\/\/pabau.com\/templates\/medication-review\/\">medication review<\/a> before the appointment matters too, since caffeine and methylxanthines blunt adenosine&#8217;s effect.<\/p>\n\n\n\n<h2 id=\"h-payer-coverage-and-prior-authorization-for-hcpcs-code-j0153\" class=\"wp-block-heading\">Payer coverage and prior authorization for HCPCS code J0153<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medicare Part B covers adenosine injection (J0153) for pharmacological cardiac stress testing when the clinical documentation supports medical necessity. CMS Local Coverage Determinations (LCDs) issued by Medicare Administrative Contractors (MACs) govern the specific covered indications. Coverage for other uses, such as SVT treatment in outpatient settings, varies by MAC jurisdiction.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Payer policy review belongs in the practice&#8217;s <a href=\"https:\/\/pabau.com\/blog\/what-is-healthcare-revenue-cycle-management\/\">revenue cycle management<\/a> routine rather than in a scramble after the first denial. LCDs change between the annual code updates, and nobody sends a reminder.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Medicare Part B:<\/strong> Covers adenosine for pharmacological stress testing. The record must document why exercise stress was inadequate and show a clinically appropriate imaging protocol.<\/li>\n\n\n\n<li><strong>Commercial payers:<\/strong> Coverage criteria vary significantly by plan. Some require preauthorization for nuclear stress tests and others do not, so verify benefits before scheduling.<\/li>\n\n\n\n<li><strong>Prior authorization:<\/strong> Not universally required by Medicare for J0153 itself. The accompanying imaging CPT may still trigger a review under commercial plans.<\/li>\n\n\n\n<li><strong>MAC LCD review:<\/strong> Pull the relevant LCD from your MAC&#8217;s website before billing adenosine for any indication outside standard stress testing protocols.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-documentation-requirements-for-j0153-claims\" class=\"wp-block-heading\">Documentation requirements for J0153 claims<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Every J0153 claim rests on three documented facts. The record has to show which drug was given, how much of it, and why the patient needed pharmacological stress. Auditors read the clinical note, not the claim form, so anything missing from the chart is effectively missing from the claim.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Drug name as printed on the vial:<\/strong> The generic or branded product name, with the manufacturer noted.<\/li>\n\n\n\n<li><strong>NDC and lot number:<\/strong> The 11-digit NDC from the administered vial or the pharmacy dispensing record, plus lot and expiration date.<\/li>\n\n\n\n<li><strong>Total dose in milligrams:<\/strong> Recorded as a number rather than a protocol name, since the unit count is derived from it.<\/li>\n\n\n\n<li><strong>Route and timing:<\/strong> Infusion route with start and stop times, which support both the drug line and the stress test CPT.<\/li>\n\n\n\n<li><strong>Any discarded amount:<\/strong> Documented in the record whenever a JW modifier is reported on the claim.<\/li>\n\n\n\n<li><strong>Clinical indication:<\/strong> The ordering physician&#8217;s stated reason, including why exercise stress testing was inadequate or contraindicated.<\/li>\n\n\n\n<li><strong>Supervision:<\/strong> Evidence that the required level of physician supervision was in place during the infusion.<\/li>\n\n\n\n<li><strong>Adverse reactions:<\/strong> Any reaction to the infusion and the treatment given in response.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Clean <a href=\"https:\/\/pabau.com\/blog\/medical-forms-at-your-healthcare-practice\/\">medical forms<\/a> that capture these fields at the point of care cut the risk of medical necessity denials sharply. A structured <a href=\"https:\/\/pabau.com\/templates\/medication-log\/\">medication log template<\/a> gives the infusion nurse one place to record drug, dose, lot, and time.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Rebuilding a record months later, from a partial infusion log and a nurse&#8217;s memory, rarely satisfies an auditor. Storage and retrieval matter as much as capture, which is where <a href=\"https:\/\/pabau.com\/blog\/hipaa-compliance-for-medical-offices\/\">HIPAA compliance<\/a> for medical offices sets the bar.<\/p>\n\n\n\n<h2 id=\"h-how-to-bill-j0153-step-by-step-claim-submission\" class=\"wp-block-heading\">How to bill J0153: Step-by-step claim submission<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Code lookup is only the first step. The workflow below runs from clinical confirmation through to claim submission.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Confirm the drug administered:<\/strong> Verify the administered drug is adenosine and not an adenosine phosphate compound. Pull the drug name and NDC straight from the vial or the pharmacy dispensing record.<\/li>\n\n\n\n<li><strong>Calculate units:<\/strong> Divide the total administered dose in mg by 1. If the patient received 18 mg, report 18 units of J0153.<\/li>\n\n\n\n<li><strong>Identify the NDC:<\/strong> Read the NDC off the vial label. Labels often print 10 digits, so pad the short segment with a leading zero to reach the 5-4-2 format payers expect. Mylan&#8217;s adenosine 3 mg\/mL vial is labeled 67457-856-20, which becomes 67457-0856-20 on the claim. Confirm the NDC still maps to J0153 in the current CMS crosswalk, published with the <a href=\"https:\/\/www.cms.gov\/medicare\/payment\/part-b-drugs\/asp-pricing-files\" target=\"_blank\" rel=\"nofollow noopener\">quarterly ASP pricing files<\/a>.<\/li>\n\n\n\n<li><strong>Select the place of service:<\/strong> Confirm whether the service was delivered in a physician office (POS 11), outpatient hospital (POS 22), or ASC (POS 24). The reimbursement rate differs by setting.<\/li>\n\n\n\n<li><strong>Pair with the correct CPT:<\/strong> Attach the applicable imaging or monitoring CPT from the pairing table above. Check that the ICD-10 diagnosis supports medical necessity for both the drug and the procedure.<\/li>\n\n\n\n<li><strong>Submit the claim:<\/strong> Report J0153 on its own line with units, NDC, the UN qualifier, and the NDC dose quantity. Submit it alongside the CPT codes for the stress test and imaging.<\/li>\n<\/ol>\n\n\n\n<h2 id=\"h-common-billing-errors-and-compliance-risks-with-hcpcs-code-j0153\" class=\"wp-block-heading\">Common billing errors and compliance risks with HCPCS code J0153<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Adenosine claims have a predictable set of failure patterns. Practices that track their denial reasons find the same errors arriving in batches. Fixing the root cause on one claim reduces exposure across an entire service line.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Error<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">What goes wrong<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Prevention<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Using J0153 for adenosine phosphate<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Compliance violation; potential fraud exposure<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Verify drug name and NDC at dispensing; build a charge master edit that blocks J0153 for non-adenosine NDCs<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Omitting the NDC<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Automatic denial by Medicare; returned for correction<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Make NDC a required field in the billing workflow before claim release<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billing deleted codes J0150, J0151, or J0152<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Automatic rejection; claim requires resubmission with J0153<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Audit charge master annually; deactivate deleted codes immediately upon CMS annual update<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Reporting a discontinued brand NDC<\/td>\n<td style=\"padding:12px 16px;color:#374151\">NDC fails the crosswalk edit and the drug line denies<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Replace legacy Adenocard and Adenoscan NDCs in the charge master with the generic product you actually stock<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Incorrect unit count<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Underpayment (if too few units) or overpayment recovery (if too many)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Train nurses and infusion staff to document exact dose in mg in the clinical note<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Wrong place of service<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Incorrect fee schedule applied; potential overpayment or underpayment<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Confirm POS code matches the actual service location before submission<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Missing medical necessity documentation<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Medical necessity denial on audit or prepayment review<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Document why exercise stress testing was contraindicated or inadequate; attach relevant ICD-10 diagnosis codes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Review your payer&#8217;s Local Coverage Determination for myocardial perfusion imaging at least once per year. MAC LCDs for cardiac stress testing updated in recent years have added documentation requirements that were not present in older versions. A claim that passed review in 2022 may now require additional clinical evidence of medical necessity.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-how-practice-management-software-keeps-j0153-claims-clean\" class=\"wp-block-heading\">How practice management software keeps J0153 claims clean<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most adenosine denials start well upstream of the biller. The dose sits in a nursing note. The NDC was on a vial that has already been discarded, and the charge master still carries a code CMS retired in 2015. By the time anyone builds the claim, the evidence has scattered across three systems.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau keeps those pieces in one patient record. The drug, dose, NDC, and administration times are captured at the point of care. The biller then works from the same chart the clinician wrote in. Nothing has to be rekeyed between systems, which is where most unit-count errors are born.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&#8217;s claims management tools carry those fields onto the claim itself. They apply the fee schedule that matches the place of service. A J0153 line with no NDC attached is flagged before it goes out. Every subscription includes them, so none of this sits behind a higher plan.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The outcome is fewer returned claims and far less time spent rebuilding documentation for an audit. Your coders stop chasing the infusion room for a number that belongs in the chart. Adenosine claims go out right the first time.<\/p>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Automate drug billing workflows in your practice                <\/h3>\n\n                <p class=\"description\">\n                    Pabau&#8217;s claims management software helps cardiology and multi-specialty practices track drug administration, attach NDCs automatically, and submit clean J-code claims the first time.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau practice management software dashboard\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 id=\"h-conclusion\" class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J0153 is a straightforward per-unit drug code with a compliance trap built into its descriptor. Document the dose precisely, verify the NDC at dispensing, and pair the drug with the right imaging CPT. Practices that do those three things see far fewer denials on adenosine claims.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Two housekeeping jobs are worth an afternoon. Clear J0150, J0151, and J0152 out of the charge master, since all three are long gone. Then swap any legacy Adenocard or Adenoscan NDC for the generic product on your shelf, because the branded versions are discontinued.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&#8217;s <a href=\"https:\/\/pabau.com\/features\/claims-management-software\/\">claims management software<\/a> builds these checks into the billing workflow, so coders spend less time verifying by hand. <a href=\"https:\/\/pabau.com\/book-demo\/\">Book a demo<\/a> to see how drug claim submission, NDC tracking, and payer-specific rules run in one system.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing the stress test itself, not just the drug?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-93015\/\">CPT code 93015<\/a> breaks down supervision, components, and the split-billing rules that decide whether the J0153 line survives.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need the administration code for a rapid IV push?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-96374\/\">CPT code 96374<\/a> covers push billing, the modifiers involved, and the documentation payers ask for.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Comparing tools that scrub claims before they go out?<\/strong> <a href=\"https:\/\/pabau.com\/blog\/claims-management-software-pabau-vs-waystar\/\">Pabau vs. Waystar<\/a> compares how each one handles claim edits, submission, and denial follow-up.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing an infusion catheter alongside the drug?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-c1751\/\">HCPCS code C1751<\/a> explains device coding and the packaging rules that apply in outpatient settings.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Coding anesthesia for a cardiac catheterization?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-01920\/\">CPT code 01920<\/a> sets out base units, time reporting, and the modifiers that go with cath lab cases.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-frequently-asked-questions\" class=\"wp-block-heading\">Frequently asked questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1786522079565\"><h3 class=\"schema-faq-question\">What is HCPCS code J0153?<\/h3> <p class=\"schema-faq-answer\">HCPCS code J0153 is the active billing code for injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds). It is billed per 1 mg unit and is used primarily for pharmacological cardiac stress testing, including nuclear myocardial perfusion imaging. The code took effect on January 1, 2015, replacing the deleted codes J0150 and J0151.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786522079566\"><h3 class=\"schema-faq-question\">What is the Medicare reimbursement rate for J0153?<\/h3> <p class=\"schema-faq-answer\">The Medicare reimbursement rate for J0153 is calculated using the ASP (Average Sales Price) + 6% methodology and is updated by CMS every quarter. Because rates change quarterly, no static figure in a reference article remains current for long. Pull the current rate before submitting claims or verifying payment expectations. Use the CMS Physician Fee Schedule lookup or the quarterly ASP drug pricing file.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786522079567\"><h3 class=\"schema-faq-question\">What is the difference between J0150, J0151, J0152, and J0153?<\/h3> <p class=\"schema-faq-answer\">J0150 covered adenosine for therapeutic use in 6 mg increments, and J0151 covered diagnostic use in 1 mg increments. Both were deleted on January 1, 2015 and consolidated into J0153. J0152 (adenosine for diagnostic use, 30 mg) was deleted a year earlier, on January 1, 2014. J0153 is the only active adenosine injection code, billed per 1 mg whatever the clinical intent.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786522079568\"><h3 class=\"schema-faq-question\">Which NDC codes map to HCPCS J0153?<\/h3> <p class=\"schema-faq-answer\">Multiple NDC codes map to J0153, and today they are almost all generic adenosine injection products. The branded versions from Astellas Pharma US, Adenocard and Adenoscan, are listed by FDA as discontinued. Generic manufacturers and NDC assignments change often, so verify the specific NDC against the current CMS NDC-to-HCPCS crosswalk file before submission. CMS publishes that file alongside its quarterly ASP pricing data.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786522079569\"><h3 class=\"schema-faq-question\">Can J0153 be used to bill adenosine phosphate compounds?<\/h3> <p class=\"schema-faq-answer\">No. The phrase &#8220;not to be used to report any adenosine phosphate compounds&#8221; is embedded in the official J0153 descriptor. Adenosine phosphate compounds are chemically distinct products with their own applicable billing codes. Using J0153 for an adenosine phosphate compound is a billing compliance violation regardless of payer, and may constitute a false claim under Medicare audit.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786522079570\"><h3 class=\"schema-faq-question\">What is the correct unit of service for J0153?<\/h3> <p class=\"schema-faq-answer\">J0153 is billed per 1 mg of adenosine administered. If the clinical record documents a total dose of 24 mg, report 24 units on the claim. Coders should verify the administered dose in the infusion record or nursing note rather than assume a standard dose. Actual doses vary by patient weight and clinical protocol.<\/p> <\/div> <\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>HCPCS code J0153 is the current active code for adenosine injection, billed per 1 mg. The Centers for Medicare and Medicaid Services (CMS) maintains the official descriptor. It reads &#8220;Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds).&#8221; That parenthetical exclusion carries the same weight as the rest of the [&hellip;]<\/p>\n","protected":false},"author":82,"featured_media":176225,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"78","_yoast_wpseo_content_score":"30","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1433,1548],"tags":[2387,1611,2953,1625,3044],"class_list":["post-176226","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-billing-codes","category-hcpcs","tag-claim-denials","tag-hcpcs-codes","tag-j-code-billing","tag-j-codes","tag-medicare-part-b"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HCPCS code J0153: Adenosine 1 mg billing without denials<\/title>\n<meta name=\"description\" content=\"J0153 covers adenosine at 1 mg per unit. It replaced J0150 and J0151 in 2015, and every Part B claim needs the NDC attached.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HCPCS code J0153: Adenosine 1 mg billing without denials\" \/>\n<meta property=\"og:description\" content=\"J0153 covers adenosine at 1 mg per unit. It replaced J0150 and J0151 in 2015, and every Part B claim needs the NDC attached.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-12T13:18:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-13T06:57:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0153.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Maja Popovska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maja Popovska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/\"},\"author\":{\"name\":\"Maja Popovska\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#\\\/schema\\\/person\\\/b00aec1dd379f0ddcf6137d78e2a21db\"},\"headline\":\"HCPCS code J0153: Adenosine injection 1 mg billing guide\",\"datePublished\":\"2026-08-12T13:18:00+00:00\",\"dateModified\":\"2026-08-13T06:57:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/\"},\"wordCount\":3592,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0153.webp\",\"keywords\":[\"Claim denials\",\"Hcpcs Codes\",\"J Code Billing\",\"J Codes\",\"Medicare Part B\"],\"articleSection\":[\"Billing Codes\",\"HCPCS\"],\"inLanguage\":\"nl-NL\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/\",\"name\":\"HCPCS code J0153: Adenosine 1 mg billing without denials\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0153.webp\",\"datePublished\":\"2026-08-12T13:18:00+00:00\",\"dateModified\":\"2026-08-13T06:57:09+00:00\",\"description\":\"J0153 covers adenosine at 1 mg per unit. It replaced J0150 and J0151 in 2015, and every Part B claim needs the NDC attached.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079565\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079566\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079567\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079568\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079569\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079570\"}],\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0153.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0153.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/#\\\/schema\\\/person\\\/b00aec1dd379f0ddcf6137d78e2a21db\",\"name\":\"Maja Popovska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Maja-Popovska_WP-1-96x96.jpeg\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Maja-Popovska_WP-1-96x96.jpeg\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Maja-Popovska_WP-1-96x96.jpeg\",\"caption\":\"Maja Popovska\"},\"description\":\"Maja is a Senior Content Writer at Pabau, where she covers everything from practice management and compliance to medical aesthetics and patient experience. Off the clock: binging true crime docuseries, baking and dreaming about travel.\",\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/blog\\\/author\\\/maja-popovska\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079565\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079565\",\"name\":\"What is HCPCS code J0153?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"HCPCS code J0153 is the active billing code for injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds). It is billed per 1 mg unit and is used primarily for pharmacological cardiac stress testing, including nuclear myocardial perfusion imaging. The code took effect on January 1, 2015, replacing the deleted codes J0150 and J0151.\",\"inLanguage\":\"nl-NL\"},\"inLanguage\":\"nl-NL\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079566\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079566\",\"name\":\"What is the Medicare reimbursement rate for J0153?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Medicare reimbursement rate for J0153 is calculated using the ASP (Average Sales Price) + 6% methodology and is updated by CMS every quarter. Because rates change quarterly, no static figure in a reference article remains current for long. Pull the current rate before submitting claims or verifying payment expectations. Use the CMS Physician Fee Schedule lookup or the quarterly ASP drug pricing file.\",\"inLanguage\":\"nl-NL\"},\"inLanguage\":\"nl-NL\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079567\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079567\",\"name\":\"What is the difference between J0150, J0151, J0152, and J0153?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J0150 covered adenosine for therapeutic use in 6 mg increments, and J0151 covered diagnostic use in 1 mg increments. Both were deleted on January 1, 2015 and consolidated into J0153. J0152 (adenosine for diagnostic use, 30 mg) was deleted a year earlier, on January 1, 2014. J0153 is the only active adenosine injection code, billed per 1 mg whatever the clinical intent.\",\"inLanguage\":\"nl-NL\"},\"inLanguage\":\"nl-NL\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079568\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079568\",\"name\":\"Which NDC codes map to HCPCS J0153?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Multiple NDC codes map to J0153, and today they are almost all generic adenosine injection products. The branded versions from Astellas Pharma US, Adenocard and Adenoscan, are listed by FDA as discontinued. Generic manufacturers and NDC assignments change often, so verify the specific NDC against the current CMS NDC-to-HCPCS crosswalk file before submission. CMS publishes that file alongside its quarterly ASP pricing data.\",\"inLanguage\":\"nl-NL\"},\"inLanguage\":\"nl-NL\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079569\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079569\",\"name\":\"Can J0153 be used to bill adenosine phosphate compounds?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. The phrase \\\"not to be used to report any adenosine phosphate compounds\\\" is embedded in the official J0153 descriptor. Adenosine phosphate compounds are chemically distinct products with their own applicable billing codes. Using J0153 for an adenosine phosphate compound is a billing compliance violation regardless of payer, and may constitute a false claim under Medicare audit.\",\"inLanguage\":\"nl-NL\"},\"inLanguage\":\"nl-NL\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079570\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/nl\\\/procedure-codes\\\/hcpcs-code-j0153\\\/#faq-question-1786522079570\",\"name\":\"What is the correct unit of service for J0153?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J0153 is billed per 1 mg of adenosine administered. If the clinical record documents a total dose of 24 mg, report 24 units on the claim. Coders should verify the administered dose in the infusion record or nursing note rather than assume a standard dose. Actual doses vary by patient weight and clinical protocol.\",\"inLanguage\":\"nl-NL\"},\"inLanguage\":\"nl-NL\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HCPCS code J0153: Adenosine 1 mg billing without denials","description":"J0153 covers adenosine at 1 mg per unit. It replaced J0150 and J0151 in 2015, and every Part B claim needs the NDC attached.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/","og_locale":"nl_NL","og_type":"article","og_title":"HCPCS code J0153: Adenosine 1 mg billing without denials","og_description":"J0153 covers adenosine at 1 mg per unit. It replaced J0150 and J0151 in 2015, and every Part B claim needs the NDC attached.","og_url":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-08-12T13:18:00+00:00","article_modified_time":"2026-08-13T06:57:09+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0153.webp","type":"image\/webp"}],"author":"Maja Popovska","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"Geschreven door":"Maja Popovska","Geschatte leestijd":"12 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/"},"author":{"name":"Maja Popovska","@id":"https:\/\/pabau.com\/nl\/#\/schema\/person\/b00aec1dd379f0ddcf6137d78e2a21db"},"headline":"HCPCS code J0153: Adenosine injection 1 mg billing guide","datePublished":"2026-08-12T13:18:00+00:00","dateModified":"2026-08-13T06:57:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/"},"wordCount":3592,"publisher":{"@id":"https:\/\/pabau.com\/nl\/#organization"},"image":{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0153.webp","keywords":["Claim denials","Hcpcs Codes","J Code Billing","J Codes","Medicare Part B"],"articleSection":["Billing Codes","HCPCS"],"inLanguage":"nl-NL"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/","url":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/","name":"HCPCS code J0153: Adenosine 1 mg billing without denials","isPartOf":{"@id":"https:\/\/pabau.com\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0153.webp","datePublished":"2026-08-12T13:18:00+00:00","dateModified":"2026-08-13T06:57:09+00:00","description":"J0153 covers adenosine at 1 mg per unit. It replaced J0150 and J0151 in 2015, and every Part B claim needs the NDC attached.","mainEntity":[{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079565"},{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079566"},{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079567"},{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079568"},{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079569"},{"@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079570"}],"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0153.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0153.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/nl\/#website","url":"https:\/\/pabau.com\/nl\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/pabau.com\/nl\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/pabau.com\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/nl\/#\/schema\/person\/b00aec1dd379f0ddcf6137d78e2a21db","name":"Maja Popovska","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-Maja-Popovska_WP-1-96x96.jpeg","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-Maja-Popovska_WP-1-96x96.jpeg","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-Maja-Popovska_WP-1-96x96.jpeg","caption":"Maja Popovska"},"description":"Maja is a Senior Content Writer at Pabau, where she covers everything from practice management and compliance to medical aesthetics and patient experience. Off the clock: binging true crime docuseries, baking and dreaming about travel.","url":"https:\/\/pabau.com\/nl\/blog\/author\/maja-popovska\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079565","position":1,"url":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079565","name":"What is HCPCS code J0153?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"HCPCS code J0153 is the active billing code for injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds). It is billed per 1 mg unit and is used primarily for pharmacological cardiac stress testing, including nuclear myocardial perfusion imaging. The code took effect on January 1, 2015, replacing the deleted codes J0150 and J0151.","inLanguage":"nl-NL"},"inLanguage":"nl-NL"},{"@type":"Question","@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079566","position":2,"url":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079566","name":"What is the Medicare reimbursement rate for J0153?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The Medicare reimbursement rate for J0153 is calculated using the ASP (Average Sales Price) + 6% methodology and is updated by CMS every quarter. Because rates change quarterly, no static figure in a reference article remains current for long. Pull the current rate before submitting claims or verifying payment expectations. Use the CMS Physician Fee Schedule lookup or the quarterly ASP drug pricing file.","inLanguage":"nl-NL"},"inLanguage":"nl-NL"},{"@type":"Question","@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079567","position":3,"url":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079567","name":"What is the difference between J0150, J0151, J0152, and J0153?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J0150 covered adenosine for therapeutic use in 6 mg increments, and J0151 covered diagnostic use in 1 mg increments. Both were deleted on January 1, 2015 and consolidated into J0153. J0152 (adenosine for diagnostic use, 30 mg) was deleted a year earlier, on January 1, 2014. J0153 is the only active adenosine injection code, billed per 1 mg whatever the clinical intent.","inLanguage":"nl-NL"},"inLanguage":"nl-NL"},{"@type":"Question","@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079568","position":4,"url":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079568","name":"Which NDC codes map to HCPCS J0153?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Multiple NDC codes map to J0153, and today they are almost all generic adenosine injection products. The branded versions from Astellas Pharma US, Adenocard and Adenoscan, are listed by FDA as discontinued. Generic manufacturers and NDC assignments change often, so verify the specific NDC against the current CMS NDC-to-HCPCS crosswalk file before submission. CMS publishes that file alongside its quarterly ASP pricing data.","inLanguage":"nl-NL"},"inLanguage":"nl-NL"},{"@type":"Question","@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079569","position":5,"url":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079569","name":"Can J0153 be used to bill adenosine phosphate compounds?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"No. The phrase \"not to be used to report any adenosine phosphate compounds\" is embedded in the official J0153 descriptor. Adenosine phosphate compounds are chemically distinct products with their own applicable billing codes. Using J0153 for an adenosine phosphate compound is a billing compliance violation regardless of payer, and may constitute a false claim under Medicare audit.","inLanguage":"nl-NL"},"inLanguage":"nl-NL"},{"@type":"Question","@id":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079570","position":6,"url":"https:\/\/pabau.com\/nl\/procedure-codes\/hcpcs-code-j0153\/#faq-question-1786522079570","name":"What is the correct unit of service for J0153?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J0153 is billed per 1 mg of adenosine administered. If the clinical record documents a total dose of 24 mg, report 24 units on the claim. Coders should verify the administered dose in the infusion record or nursing note rather than assume a standard dose. Actual doses vary by patient weight and clinical protocol.","inLanguage":"nl-NL"},"inLanguage":"nl-NL"}]}},"yoast":{"focus_keyword":"HCPCS code J0153","seo_title":"HCPCS code J0153: Adenosine 1 mg billing without denials","meta_description":"J0153 covers adenosine at 1 mg per unit. It replaced J0150 and J0151 in 2015, and every Part B claim needs the NDC attached.","content_score":"30","is_cornerstone":"","related_keyphrases":[{"keyword":"J0153 fee schedule","score":61},{"keyword":"J0153 NDC crosswalk","score":61},{"keyword":"adenosine cardiac stress test HCPCS","score":56}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/posts\/176226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/comments?post=176226"}],"version-history":[{"count":4,"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/posts\/176226\/revisions"}],"predecessor-version":[{"id":177357,"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/posts\/176226\/revisions\/177357"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/media\/176225"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/media?parent=176226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/categories?post=176226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/nl\/wp-json\/wp\/v2\/tags?post=176226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}